Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.

ABSTRACT:

SUBMITTER: Louis E 

PROVIDER: S-EPMC9908559 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature